Form 4: Prestige Consumer Healthcare Director Celeste A. Clark Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Celeste A. Clark reports acquisition of 2,202 restricted stock units of Prestige Consumer Healthcare Inc. as part of the director compensation program.

Summary

  • On August 6, 2024, Celeste A. Clark, a director of Prestige Consumer Healthcare Inc., acquired 2,202 restricted stock units.
  • These units were granted as part of the Issuer's director compensation program.
  • The value of the restricted stock units is equivalent to $150,000, calculated using a closing stock price of $68.13 on the grant date.
  • The restricted stock units vest on the first anniversary of the grant.
  • Upon vesting, each unit will be settled by delivering one share of Prestige Consumer Healthcare Inc.'s common stock to the Reporting Person.
  • Settlement will occur promptly following the earliest of the Reporting Person's death, separation, or a change in control.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The grant of restricted stock units can be seen as a positive sign of aligning director interests with shareholder value.

Positives

  • The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Director compensation in the form of restricted stock units is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

  • Granting restricted stock units to directors is a standard practice among publicly traded companies.
  • The vesting period of one year is fairly typical for such grants.
  • Companies like Johnson & Johnson and Procter & Gamble also use similar equity-based compensation for their board members.

Stakeholder Impact

  • The acquisition of restricted stock units by a director can positively influence shareholder confidence by aligning management's interests with shareholder value.

Key Dates

DateDescription
May 4, 2021Date of Power of Attorney on file with the Commission.
August 6, 2024Date of transaction: Acquisition of 2,202 restricted stock units.
August 7, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.